Pharming gives update on outstanding number of shares
(Thomson Reuters ONE) - Leiden, The Netherlands, August 28, 2009. Biotech company PharmingGroup NV ("Pharming") (NYSE Euronext: PHARM) today provided an updateon its outstanding number of shares following a transaction with YAGlobal Master SPV LTD ("YA Global").Under the Standby Equity Distribution Agreement (SEDA) with YAGlobal, Pharming issued 773,568 ordinary shares for a cashconsideration of ? 0.4 million. As a result of the abovetransactions, Pharming's total number of outstanding ordinary sharesis currently 113,936,555 shares.Chief Executive Officer of Pharming, Sijmen de Vries: "We continue tobe very pleased with the YA Global SEDA, as it provides us with theflexibility of being able to step- wise raise new funds to supportour balance sheet position, thus minimising dilution for our currentshareholders, whilst at the same time we are working on several othertypes of transactions including (convertible) debt, project-specificfinancing and licensing deals."About Pharming Group NVPharming Group NV is developing innovative products for the treatmentof genetic disorders, ageing diseases, specialty products forsurgical indications, intermediates for various applications andnutritional products. Pharming has two products in late stagedevelopment - Rhucin® for Hereditary Angioedema and human Lactoferrinfor use in food products and one product in early stage clinicaldevelopment - Prodarsan® for Cockayne Syndrome. The advancedtechnologies of the Company include innovative platforms for theproduction of protein therapeutics, technology and processes for thepurification and formulation of these products, as well as technologyin the field of DNA repair (via DNage). Additional information isavailable on the Pharming website, http://www.pharming.com.This press release contains forward looking statements that involveknown and unknown risks, uncertainties and other factors, which maycause the actual results, performance or achievements of the Companyto be materially different from the results, performance orachievements expressed or implied by these forward lookingstatements.Contact:Sijmen de Vries, Pharming Group NV, T: +31 (0)71 52 47 400http://hugin.info/132866/R/1337725/318889.pdfThis announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
Datum: 28.08.2009 - 08:01 Uhr
Sprache: Deutsch
News-ID 5208
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 342 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Pharming gives update on outstanding number of shares"
steht unter der journalistisch-redaktionellen Verantwortung von
Pharming Group N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
